Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Endo Pharmaceuticals to Change Name to Endo Health Solutions

March 1 (Bloomberg) -- Endo Pharmaceuticals Holdings Inc., maker of the Opana ER painkiller, plans to change its name to Endo Health Solutions Inc. to reflect that the company’s range of products has expanded

The new name will “reflect the company’s significant transformation,” Chadds Ford Pennsylvania-based Endo said in a statement today.

Endo’s products now include devices, practice management software and both branded and generic drugs after acquisitions including the $2.9 billion purchase of American Medical Systems Holding Inc. announced in April 2011. The company will ask shareholders to approve the new name at its annual shareholder meeting in May.

“We made all these acquisitions in rapid form, so then we had an identity issue,” said Chief Executive Officer David Holveck, in a telephone interview. “You’ve got to say who you are and what you’re trying to deliver.”

This year, the company will focus on growing its new businesses and making sure they all fit together, Holveck said.

To contact the reporter on this story: Elizabeth Lopatto in New York at elopatto@bloomberg.net

To contact the editor responsible for this story: Reg Gale at rgale5@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.